AMLX vs UBER · rev $87.4M vs P/E 18, rev $52.02B
Amylyx Pharmaceuticals Inc (AMLX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
AMLX currently screens at market cap $561.6M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the AMLX and UBER stock pages for the full models.
Not investment advice.